Aristotle Capital Management, LLC
Position in JAZZ — Jazz Pharmaceuticals plc
CIK 860644
LOS ANGELES, CA
Position in JAZZ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,915,626
+$2,236,094 QoQ
Shares Held
111,697
-14.4% QoQ
Ownership
0.172%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#78
of 643 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aristotle Capital Management, LLC holds $26,915,626 across 1 Biotechnology name. JAZZ ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
111,697 | $26,915,626 |
All Filings in JAZZ
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,915,626 | 111,697 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $24,679,532 | 130,545 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $27,002,290 | 158,837 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $20,831,780 | 158,056 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $17,570,288 | 165,570 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $19,723,213 | 158,866 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $24,129,764 | 195,938 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $23,695,904 | 212,691 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $21,050,998 | 197,236 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $23,715,876 | 196,943 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $24,256,092 | 197,204 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $22,749,986 | 175,757 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||